Galectin Therapeutics Inc. GALT today
announced the appointment of Dr. Harold H. Shlevin as Chief Operating Officer.
Dr. Shlevin succeeds, as of October 1, 2012, Maureen Foley who helped found
the Company and served as its COO since its inception and as its corporate
secretary. Dr. Shlevin is a bioscience industry executive with 25 years of
senior management experience in the development and commercialization of
pharmaceuticals, diagnostics and vaccines.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsManagement
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in